Of a £400m spend, £58m of savings elsewhere had been achieved and she demonstrated this with examples of procurement of hepatitis C drugs and use of biosimilars (which Dr Alan MacDonald, Chair of the Scottish Medicines Consortium also describediiHealth and Sport Committee, Official Report, 21 January 2020, Col 42 as a "good news story").
Gail Caldwell, Director of Pharmacy, NHS Greater Glasgow and ClydeiiHealth and Sport Committee, Official Report, 4 February 2020, Col 26 told us medicines represented 17% of board expenditure in Scotland.